Provided by Tiger Trade Technology Pte. Ltd.

iBio

1.43
-0.0400-2.72%
Post-market: 1.430.00000.00%19:56 EDT
Volume:755.21K
Turnover:1.11M
Market Cap:71.04M
PE:-2.55
High:1.50
Open:1.46
Low:1.42
Close:1.47
52wk High:3.82
52wk Low:0.7440
Shares:49.68M
Float Shares:34.88M
Volume Ratio:0.56
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5600
EPS(LYR):-1.7504
ROE:-62.09%
ROA:-34.50%
PB:0.92
PE(LYR):-0.82

Loading ...

iBio doses first patient in Phase 1 trial of obesity drug candidate IBIO-600

Reuters
·
Jun 02

Ibio Becomes a Clinical-Stage Company With First Participant Dosed in Phase 1 Clinical Trial of Ibio-600 in Adults With Obesity

THOMSON REUTERS
·
Jun 02

IBIO-600 First-in-Human Obesity Trial Puts iBio on Investors’ Radar

TIPRANKS
·
May 30

LifeSci Capital Remains a Buy on Ibio (IBIO)

TIPRANKS
·
May 16

iBio files Form 3 as director Elizabeth Stoner reports no beneficial ownership

Reuters
·
May 15

Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)

TIPRANKS
·
May 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

TIPRANKS
·
May 13

BRIEF-Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update

Reuters
·
May 13

iBio reports Q3 EPS (7c), consensus (6c)

TIPRANKS
·
May 13

iBio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

iBio Q3 EPS $(0.07) Misses $(0.06) Estimate

Benzinga Earnings
·
May 13

iBio wins Australian clearance to start Phase 1 trial of obesity drug IBIO-600

Reuters
·
May 13

iBio FY26 Q3 net loss widens to $7.73 million; operating loss widens to $8.37 million

Reuters
·
May 13

Ibio Inc - Reports No Revenue for Q3 Ended March 31, 2026

THOMSON REUTERS
·
May 13

Ibio Inc: Qtrly Loss per Share $-0.07

THOMSON REUTERS
·
May 13

iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 13

iBio Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
May 08

iBio names Elizabeth Stoner to board as Schimmelpennink steps down

Reuters
·
May 08

Ibio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to Its Board of Directors

THOMSON REUTERS
·
May 08

Press Release: iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors

Dow Jones
·
May 08